In this interview, Dr. Chopra discusses the comprehensive management of insomnia in patients with major depressive disorder (MDD), emphasizing the effectiveness of cognitive behavioral therapy for insomnia (CBT-I), in both traditional and digital forms, as a first-line treatment. Additionally, he explores pharmacologic approaches, including benzodiazepines, nonbenzodiazepine hypnotics, dual orexin receptor antagonists (DORAs), and the potential benefits of ketamine in treatment-resistant cases in reducing insomnia severity. Dr. Chopra also emphasizes the importance of screening for comorbidities such as obstructive sleep apnea when managing insomnia in patients with MDD.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/navigating-insomnia-and-other-sleep-disorders-in-depression-interview-2808?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-06-01 05:00:00
- End Date: 2024-06-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest